SCHEMBL5156769

SCHEMBL5156769

Cc1cc(N)c[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21026422 0.71
SCHEMBL19007328 0.67
SCHEMBL28841868 0.67 DAO (0.32)
SCHEMBL24091386 0.67
SCHEMBL5175439 0.67
SCHEMBL28127490 0.67
SCHEMBL23241465 0.63
SCHEMBL25421633 0.62
SCHEMBL12778243 0.62
SCHEMBL7253514 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US claimed
WO-2023014793-A1 PROCESS FOR POLYAMIDE SYNTHESIS Design Therapeutics, Inc. (US) 2023-02-09 WO disclosed
CN-110038134-A The Nano medication transmission system and preparation method of double responsiveness carrying anti-tumor drug for oncotherapy 南开大学 2019-07-23 CN disclosed
CN-108239071-A Amide and thioamides analog derivative and its preparation method and application 沈阳药科大学 2018-07-03 CN disclosed
CN-105503837-B Substituted quinazoline analog derivative and its application with Aurora kinase inhibitory activity 中山大学 2018-06-29 CN disclosed
CN-108191822-A A kind of synthetic method of Rynaxypyr 广东丸美生物技术股份有限公司 2018-06-22 CN disclosed
EP-3208269-A1 INHIBITORS OF C-FMS KINASE Janssen Pharmaceutica N.V. (BE) 2017-08-23 EP disclosed
CN-104844567-B Synthesis method of intermediate 1- (3-chloro-2-pyridyl) -3-bromo-1H-5-pyrazolecarboxylic acid 暨南大学 2017-03-29 CN disclosed
WO-2013017714-A1 HIGH-TEMPERATURE ORGANOGELLING COMPOUNDS UNIVERSITAT JAUME I DE CASTELLÓ (ES) 2013-02-07 WO disclosed
WO-2011050160-A1 PHARMACEUTICALS, COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME BIOGEN IDEC MA INC. (US) 2011-04-28 WO disclosed
US-7297168-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-11-20 US disclosed
EP-1737417-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2007-01-03 EP disclosed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US disclosed
WO-2005074875-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-08-18 WO disclosed
EP-0341493-A2 Optically active pyridonecarboxylic acid derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1989-11-15 EP disclosed